Are Metabolically Healthy Overweight and Obesity Benign Conditions? A Systematic Review and Meta-analysis

被引:741
作者
Kramer, Caroline K.
Zinman, Bernard
Retnakaran, Ravi [1 ]
机构
[1] Mt Sinai Hosp, Leadership Sinai Ctr Diabet, Toronto, ON M5T 3L9, Canada
关键词
BODY-MASS INDEX; NORMAL-WEIGHT; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; PUBLICATION BIAS; ALL-CAUSE; MORTALITY; RISK; PHENOTYPES; INFLAMMATION;
D O I
10.7326/0003-4819-159-11-201312030-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Recent interest has focused on a unique subgroup of overweight and obese individuals who have normal metabolic features despite increased adiposity. Normal-weight individuals with adverse metabolic status have also been described. However, it remains unclear whether metabolic phenotype modifies the morbidity and mortality associated with higher body mass index (BMI). Purpose: To determine the effect of metabolic status on all-cause mortality and cardiovascular events in normal-weight, overweight, and obese persons. Data Sources: Studies were identified from electronic databases. Study Selection: Included studies evaluated all-cause mortality or cardiovascular events (or both) and clinical characteristics of 6 patient groups defined by BMI category (normal weight/overweight/obesity) and metabolic status (healthy/unhealthy), as defined by the presence or absence of components of the metabolic syndrome by Adult Treatment Panel III or International Diabetes Federation criteria. Data Extraction: Two independent reviewers extracted the data. Metabolically healthy people of normal weight made up the reference group. Data Synthesis: Eight studies (n = 61 386; 3988 events) evaluated participants for all-cause mortality and/or cardiovascular events. Metabolically healthy obese individuals (relative risk [RR], 1.24; 95% CI, 1.02 to 1.55) had increased risk for events compared with metabolically healthy normal-weight individuals when only studies with 10 or more years of follow-up were considered. All metabolically unhealthy groups had a similarly elevated risk: normal weight (RR, 3.14; CI, 2.36 to 3.93), overweight (RR, 2.70; CI, 2.08 to 3.30), and obese (RR, 2.65; CI, 2.18 to 3.12). Limitation: Duration of exposure to the metabolic-BMI phenotypes was not described in the studies and could partially affect the estimates. Conclusion: Compared with metabolically healthy normal-weight individuals, obese persons are at increased risk for adverse long-term outcomes even in the absence of metabolic abnormalities, suggesting that there is no healthy pattern of increased weight.
引用
收藏
页码:758 / +
页数:17
相关论文
共 59 条
[21]   Effects of a lifestyle intervention in metabolically benign and malign obesity [J].
Kantartzis, K. ;
Machann, J. ;
Schick, F. ;
Rittig, K. ;
Machicao, F. ;
Fritsche, A. ;
Haering, H. -U. ;
Stefan, N. .
DIABETOLOGIA, 2011, 54 (04) :864-868
[22]   The metabolically healthy but obese individual presents a favorable inflammation profile [J].
Karelis, AD ;
Faraj, M ;
Bastard, JP ;
St Pierre, DH ;
Brochu, M ;
Prud'homme, D ;
Rabasa-Lhoret, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (07) :4145-4150
[23]   Metabolically healthy but obese individuals [J].
Karelis, Antony D. .
LANCET, 2008, 372 (9646) :1281-1283
[24]   Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: The Study of Women's Health Across the Nation (SWAN) [J].
Khan, Unab I. ;
Wang, Dan ;
Thurston, Rebecca C. ;
Sowers, MaryFran ;
Sutton-Tyrrell, Kim ;
Matthews, Karen A. ;
Barinas-Mitchell, Emma ;
Wildman, Rachel P. .
ATHEROSCLEROSIS, 2011, 217 (01) :179-186
[25]   Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women - A report from the Women's Ischemia Syndrome Evaluation (WISE) study [J].
Kip, KE ;
Marroquin, OC ;
Kelley, DE ;
Johnson, BD ;
Kelsey, SF ;
Shaw, LJ ;
Rogers, WJ ;
Reis, SE .
CIRCULATION, 2004, 109 (06) :706-713
[26]   Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials [J].
Kramer, C. K. ;
Leitao, C. B. ;
Pinto, L. C. ;
Canani, L. H. ;
Azevedo, M. J. ;
Gross, J. L. .
OBESITY REVIEWS, 2011, 12 (501) :e338-e347
[27]   Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis [J].
Kramer, Caroline Kaercher ;
Zinman, Bernard ;
Retnakaran, Ravi .
LANCET DIABETES & ENDOCRINOLOGY, 2013, 1 (01) :28-34
[28]   Are Metabolically Normal but Obese Individuals at Lower Risk for All-Cause Mortality? [J].
Kuk, Jennifer L. ;
Ardern, Chris I. .
DIABETES CARE, 2009, 32 (12) :2297-2299
[29]   Body mass index and mortality in elderly men and women: the Tromso and HUNT studies [J].
Kvamme, Jan-Magnus ;
Holmen, Jostein ;
Wilsgaard, Tom ;
Florholmen, Jon ;
Midthjell, Kristian ;
Jacobsen, Bjarne K. .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2012, 66 (07) :611-617
[30]   Obesity phenotype and incident hypertension: a prospective community-based cohort study [J].
Lee, Seung Ku ;
Kim, Seong Hwan ;
Cho, Goo-Yeong ;
Baik, Inkyung ;
Lim, Hong Euy ;
Park, Chang Gyu ;
Lee, Jung Bok ;
Kim, Yong Hyun ;
Lim, Sang Yup ;
Kim, Hyun ;
Shin, Chol .
JOURNAL OF HYPERTENSION, 2013, 31 (01) :145-151